perfosfamide has been researched along with Arthritis, Rheumatoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, K; Gao, C; Li, X; Luo, J; Qin, K; Wang, C; Wang, Q; Zhao, W; Zhao, X | 1 |
| Chen, KL; Li, XF; Luo, J; Niu, HQ; Qin, KL; Zhao, WP; Zhao, XC | 1 |
2 other study(ies) available for perfosfamide and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Methotrexate Combined with 4-Hydroperoxycyclophosphamide Downregulates Multidrug-Resistance P-Glycoprotein Expression Induced by Methotrexate in Rheumatoid Arthritis Fibroblast-Like Synoviocytes via the JAK2/STAT3 Pathway.
Topics: Apoptosis; Arthritis, Rheumatoid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cyclophosphamide; Drug Resistance, Multiple; Drug Therapy, Combination; Fibroblasts; Gene Expression Regulation; Humans; Janus Kinase 2; Methotrexate; Signal Transduction; STAT3 Transcription Factor; Synoviocytes | 2018 |
Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
Topics: Arthritis, Rheumatoid; Cells, Cultured; Cyclophosphamide; Drug Therapy, Combination; Fibroblasts; Gene Expression Regulation; Humans; Imidazoles; Interleukin-6; Janus Kinase 2; Methotrexate; p38 Mitogen-Activated Protein Kinases; Pyridines; RANK Ligand; Receptors, Interleukin-6; Signal Transduction; STAT3 Transcription Factor; Synoviocytes; Tyrphostins | 2018 |